Results

Total Results: 1,879 records

Showing results for "evaluated".

  1. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - The two reviewers also independently evaluated the applicability to real-world practice of the total … The RCTs evaluated patients who were not on oral anticoagulation therapy (OAT) and had intracerebral … • rFVIIa use vs. usual care had no effect on hematoma growth but, in the one study that evaluated it … One of the RCTs assessed prophylactic rFVIIa use, whereas the rest of the studies evaluated treatment … benefits and harms of rFVIIa, our findings include: • Mortality and thromboembolic events could not be evaluated
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - of the evidence and expert opinion supporting recommendations to update specific key questions were evaluated … For this reason, both forms of epoetin will be evaluated in this review. … LASA, VAS, and CLAS scales will be excluded Tumor response will only be evaluated in studies that … New studies will be evaluated against inclusion/exclusion criteria in the same manner as all other studies … Between-study heterogeneity will be evaluated by examining measures of between-study variability (e.g
  3. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - Identifying Harms To Be Evaluated 2 CERs should always assess harms that are important to decisionmakers … unpublished myocardial infarction data from older trials found an increased risk with high doses of all evaluated … common with cohort studies, it is difficult to establish causality because exposures, and outcomes are evaluated … exposures and outcomes, and blinded assessment of outcomes. 30,52-54 Several studies have empirically evaluated … favorable outcomes than did studies with other funding sources. 57,59 Because all of these studies evaluated
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - When no RCTs were identified that evaluated a CKD screening or monitoring intervention and reported … observational studies were not identified through a comprehensive literature search, whenever possible we evaluated … .19 For each treatment comparison and major outcome, overall strength of evidence for the RCTs was evaluated … Research and Quality and the Effective Health Care Program.20 Briefly, strength of the evidence was evaluated … Note: For all-cause mortality and end-stage renal disease, the strength of the evidence was evaluated
  5. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - Identifying Harms To Be Evaluated 2 CERs should always assess harms that are important to decisionmakers … unpublished myocardial infarction data from older trials found an increased risk with high doses of all evaluated … common with cohort studies, it is difficult to establish causality because exposures, and outcomes are evaluated … exposures and outcomes, and blinded assessment of outcomes. 30,52-54 Several studies have empirically evaluated … favorable outcomes than did studies with other funding sources. 57,59 Because all of these studies evaluated
  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
    January 01, 2006 - • No studies evaluated the comparative efficacy of salsalate or aspirin vs. a nonaspirin NSAID. … • In fair-quality meta-analyses of arthritis trials, most of which evaluated short-term use, celecoxib … and results may not be directly applicable to the United States because the positive trials primarily evaluated … medications with topical preparations • Topical NSAIDs: efficacy • Studies of topical NSAIDs typically evaluated … Balance of evidence and harms Each of the analgesics evaluated in this report was associated with a
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
    March 29, 2023 - Plants have historically been evaluated for medicinal properties, with some being developed into drug … Randomized trials will be evaluated using criteria and methods developed by the Cochrane Back Review … Group,30 and cohort and case-control studies will be evaluated using criteria developed by the U.S. … and settings in clinical practice based on the populations, interventions, comparisons, and outcomes evaluated
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
    May 01, 2025 - Summary of findings from the included cohort studies that evaluated dental procedures other than tooth … did not specify indications for medication use.39,41,44 The only retrospective cohort study that evaluated … sample size, and sample representative of the true population.39 The remaining six cohort studies, evaluated … Summary of findings from the included cohort studies that evaluated dental procedures other than tooth … In studies with mixed disease populations, we evaluated data of patients with non-malignant disease
  9. effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-34-health-worker-certification-summary.pdf
    March 01, 2020 - Four articles found in the published literature evaluated an aspect of CHW certification and addressed
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - for which active surveillance culturing of asymptomatic patients has been advocated and critically evaluated … JAMA Netw Open. 2020 3(8):e2012522. – Effect of surveillance not evaluated separately 9. … Aust Health Rev. 2021 45(1):59-65. – Effect of surveillance not evaluated separately 29. … Antimicrob Resist Infect Control. 2022 11(1):117. - Effect of surveillance not evaluated separately … – Effect of surveillance not evaluated separately 97. Yang M, Huang Y, Li Q et al.
  11. effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Given comments during peer review we re- evaluated the body of evidence and we have changed the strength … Based on comments during peer review, we re-evaluated the body of evidence, and given the small studies … We re-evaluated the body of evidence, given the comments of the reviewers, and have revised the strength … However, we re-evaluated this body of evidence and based on, the small studies (and therefore some
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
    March 24, 2017 - Given comments during peer review we re- evaluated the body of evidence and we have changed the strength … Based on comments during peer review, we re-evaluated the body of evidence, and given the small studies … We re-evaluated the body of evidence, given the comments of the reviewers, and have revised the strength … However, we re-evaluated this body of evidence and based on, the small studies (and therefore some
  13. effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
    January 01, 2010 - predefined criteria listed here have been demonstrated to influence study outcomes and should be routinely evaluated … for Observational Studies (I) Nonrandomized studies have additional sources of bias that need to be evaluated
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - .†† Most studies evaluated medications in combination with a psychosocial cointervention; the potential … The studies typically evaluated the use of medications along with psychosocial cointerventions. ��
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
    July 01, 2012 - review (or guidelines) whose results identified another treatment as significantly superior to the one evaluated … Tamoxifen reduces breast cancer outcomes in subgroups evaluated in prevention trials based on age … Raloxifene reduces breast cancer outcomes in subgroups evaluated in prevention trials based on … New Evidence: Tamoxifen reduces breast cancer outcomes in subgroups evaluated in … Raloxifene reduces breast cancer outcomes in subgroups evaluated in prevention trials based on age,
  16. effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
    January 01, 2011 - In the first study, the sensitivity and specificity of using MEDLINE versus nine databases was evaluated … English Only or All Languages (I) This study evaluated 42 systematic reviews comprising 662 RCTs. … However, when complementary and alternative medicine was evaluated, the protective effect estimate was … 63% smaller than when language-inclusive reviews were evaluated. … Grey Literature In one study, five systematic reviews were evaluated to determine the impact of grey
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Lidocaine No study in the original report evaluated this comparison. … Placebo No study in the original report evaluated this specific NSAID. … Placebo No study in the original report evaluated this comparison. … Placebo No study in the original report evaluated this comparison. … Placebo No study in the original report evaluated this comparison.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-genetic.ppt
    June 01, 2012 - analyte was investigated (e.g., specification of which alleles, genes, or biochemical analytes were evaluated … Depending on the enzyme and polymorphism being evaluated, the variation in enzyme activity over time … Assessment of newly identified polymorphisms (such as on chromosome 9p21) should be evaluated in context … Genetic association studies should generally report whether the frequencies of the alleles being evaluated … When clinical factors associated with risk are well known, genetic tests should be evaluated for added
  19. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-genetic.ppt
    June 01, 2012 - analyte was investigated (e.g., specification of which alleles, genes, or biochemical analytes were evaluated … Depending on the enzyme and polymorphism being evaluated, the variation in enzyme activity over time … Assessment of newly identified polymorphisms (such as on chromosome 9p21) should be evaluated in context … Genetic association studies should generally report whether the frequencies of the alleles being evaluated … When clinical factors associated with risk are well known, genetic tests should be evaluated for added
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/choice-of-mean_white-paper.pdf
    April 01, 2015 - We also evaluated whether the impact qualitatively varied by the comparator and alternative random … Therefore, in this meta-epidemiological study, we empirically evaluated how the choice of using change … In addition, we evaluated how different random effect models might affect the impact of the choice of … Only meta-analyses of RCTs were included in this study, and we specifically evaluated MD only. … We avoided including more than one CER that evaluated the same continuous outcome (duplicate outcome

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: